Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges
Article first published online: 18 MAY 2011
Copyright © 2011 WILEY Periodicals, Inc.
Volume 33, Issue 6, pages 478–479, June 2011
How to Cite
- Issue published online: 18 MAY 2011
- Article first published online: 18 MAY 2011
Vol. 32, Issue 9, 756–767, Article first published online: 22 JUL 2010
Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges Zsuzsanna Izsvák, Perry B. Hackett, Laurence J. N. Cooper, Zoltán Ivics
BioEssays Volume 32, Issue 9, pages 756–767, September 2010
In the above article, certain literature references to data in tables 1 and 2 were incorrectly given. The corrected table, indicating which references were affected, appears below:
19. Yant SR, Meuse L, Chiu W, et al. 2000. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet25: 35–41.
45. Liu L, Liu H, Visner G, et al. 2006. Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats. Faseb J20: 2594–6.
46. Aronovich EL, Bell JB, Khan SA, et al. 2009. Systemic correction of storage disease in MPS I NOD/SCID mice using the Sleeping Beauty transposon system. Mol Ther17: 1136–44.
47. Liu H, Liu L, Fletcher BS, et al. 2006. Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. FASEB J20: 2384–6.
49. Kren BT, Unger GM, Sjeklocha L, et al. 2009. Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J Clin Invest119: 2086–99.
55. Belur LR, Frandsen JL, Dupuy AJ, et al. 2003. Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther8: 501–7.
58. Ohlfest JR, Demorest ZL, Motooka Y, et al. 2005. Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the Sleeping Beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma. Mol Ther12: 778–88.
59. Wu A, Oh S, Ericson K, et al. 2007. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Cancer Gene Ther14: 550–60.
63. Podetz-Petersen KM, Bell JB, Steele TW, et al. 2010. Gene expression in lung and liver after intravenous infusion of polyethyleneimine complexes and hydrodynamic delivery of Sleeping Beauty transposons. Hum Gene Ther21: 210–220.
65. Montini E, Held PK, Noll M, et al. 2002. In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol Ther6: 759–69.
66. Ohlfest JR, Frandsen JL, Fritz S, et al. 2005. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood105: 2691–8.
67. Aronovich EL, Bell JB, Belur LR, et al. 2007. Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposonmediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses. J Gene Med9: 403–15.
75. Yant SR, Ehrhardt A, Mikkelsen JG, et al. 2002. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat Biotechnol20: 999–1005.
76. Bowers WJ, Mastrangelo MA, Howard DF, et al. 2006. Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. Mol Ther13: 580–8.
77. Staunstrup NH, Moldt B, Mates L, et al. 2009. Hybrid lentivirus-transposon vectors with a random integration profile in human cells. Mol Ther24: 24.
78. Vink CA, Gaspar HB, Gabriel R, et al. 2009. Sleeping Beauty transposition from nonintegrating lentivirus. Mol Ther.17: 1197–204.
114. Zhang X, Dong X, Sawyer, GJ, et al. 2004. Regional hydrodynamic gene delivery to the rat liver with physiological volumes of DNA soluEon. J. Gene Med6: 693–703.
115. Sawyer GJ, Dong X, Whitehorne M, et al. 2007. Cardiovascular funcEon following acute volume overload for hydrodynamic gene delivery to the liver. Gene Ther14: 1208–27.
116. Yoshino H, Hashizume K, Kobayashi E, 2006. Naked plasmid DNA transfer to the porcine liver using rapid injecEon with large volume. Gene Ther13: 1696–1702.
117. Khorsandi SE, Bachellier P, Weber JC, et al. 2008. Minimally invasive and selecEve hydrodynamic gene therapy of liver segments in the pig and human. Cancer Gene Ther15: 225–30.
118. Fabre, JW, Grehan A, Whitehorne M, et al. 2008. Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava. Gene Ther15: 452–62.